NVIDIA and Microsoft are collaborating to accelerate agentic AI innovation, enabling research breakthroughs across industries from the cloud to the PC.
At Microsoft Build, Microsoft introduced Microsoft Discovery, a platform for researchers to leverage agentic AI, integrating NVIDIA ALCHEMI NIM and BioNeMo microservices for materials science and drug discovery.
Microsoft is deploying NVIDIA GB200 NVL72 systems in Azure data centers, enhancing performance and efficiency with up to 35x more inference throughput for AI workloads.
The collaboration extends to healthcare microservices, generative AI on Windows 11 with RTX AI PCs, and the unveiling of an AI inferencing stack for boosting performance on Windows 11.